NINA GALLIMORE: Open Payments
NPI 1891459020 · BRYN MAWR, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 27 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $376 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 4 | $126 |
| Novo Nordisk Inc | 4 | $114 |
| PFIZER INC. | 6 | $102 |
| Alnylam Pharmaceuticals Inc. | 2 | $69 |
| Boston Scientific Corporation | 2 | $47 |
| Amgen Inc. | 3 | $43 |
| BridgeBio Pharma, Inc. | 2 | $38 |
| Daiichi Sankyo Inc. | 1 | $21 |
| ABIOMED | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $14 |
Products named: FUROSCIX, Wegovy, VYNDAQEL, ONPATTRO, WATCHMAN Access System, REPATHA, Attruby, ELIQUIS.
Industry payments across PA — which companies pay providers there.
